BREAKING
Home » Posts Tagged "BARDA" (Page 2)

Anthrax antitoxin purchased for Strategic National Stockpile

By

The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) will purchase an anthrax treatment for $25.2 million from Elusys Therapeutics...

Takeda’s Zika virus vaccine candidate progresses into Phase 1 clinical trial

By

Takeda Pharmaceuticals today announced that its purified, inactivated, alum-adjuvanted, whole Zika virus vaccine candidate (TAK-426) has progressed into a Phase 1 clinical trial, approximately 15 months...

plague

‘Combating antibiotic-resistant infections is fundamental to U.S. biodefense’: BARDA director

By

The Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services,...

Anthrax: HHS advances point-of-care diagnostic test

By

A point-of-care diagnostic test that may be able to determine within 15 minutes whether a patient has been infected with the bacterium that causes anthrax is moving forward in research and development...

Bioterrorism threats: Anthrax vaccine contract, botulism antitoxin approval in Canada

By

Last week, Gaithersburg, MD based biopharmaceutical company, Emergent BioSolutions Inc. announced the signing of a nearly $1 billion contract with the Centers for Disease Control and Prevention (CDC)...

Ebola: Iowa firm awarded contract to develop vaccine

By

An Ebola vaccine will take the next critical steps in development under a $24.75 million contract through May 2020 between the U.S. Department of Health and Human Services’ Office of the Assistant...

Zika vaccine: Sanofi Pasteur awarded $43 million to develop an inactivated vaccine

By

The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced a contract to develop an inactivated vaccine candidate to...

OraSure awarded $7 million to develop point-of-care Zika test

By

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) today announced a $7 million contract with Orasure Technologies, Inc. of Bethlehem,...

Italy-based company, DiaSorin Group, awarded $2.6 million to develop Zika test

By

The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response today announced a $2.6 million agreement with DiaSorin Group, an Italy-based company...

Zika blood screening test: HHS awards $4.1 million to Hologic

By

Today, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response announced a $4.1 million agreement with Hologic, Inc. of Marlborough, Massachusetts,...